RARE DISEASERESEARCH ATLAS

ORPHA:309192

Tay-Sachs disease, adult form

high confidenceSubtype of disorder

Also known as: Beta-hexosaminidase subunit alpha deficiency, adult form · GM2 gangliosidosis, Tay-Sachs variant, adult form · GM2 gangliosidosis, hexosaminidase A deficiency variant, adult form · HEXA disorder, adult form · Late-onset Tay-Sachs disease

Publications

123

56.2th percentile

Trials

0

Interventional, condition-specific

Researchers

523

Distinct authors in sample

Gene link

Readiness

2/6

Stages with a signal

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

GM2 gangliosidosis, B variant, adult form · hexosaminidase A deficiency, adult form

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    123 matched papers (58 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 11 for broader category Tay-Sachs disease

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

123

123 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

123 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

58 in the last 10 years · high confidence · 56.2th percentile (publications denominator)

Phrase hits: 123 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

523

Distinct author names in 123 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Shapiro BE7 papers · 2011

    Neuromuscular Division, Department of Neurology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, OH 44106-5098, USA. bes002@aol.com

    Papers in Europe PMC
  2. 02
    Kolodny EH6 papers · 2009
    Papers in Europe PMC
  3. 03
    Rucker JC6 papers · 2022

    Department of Neurology Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York 10029, USA. janet.rucker@mssm.edu

    Papers in Europe PMC
  4. 04
    Leigh RJ5 papers · 2021

    Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.

    Papers in Europe PMC
  5. 05
    Pastores GM5 papers · 2009
    Papers in Europe PMC
  6. 06
    Keller EL4 papers · 2011

    Smith-Kettlewell Eye Research Institute, San Francisco, CA, USA. elk@ski.org

    Papers in Europe PMC
  7. 07
    Navon R4 papers · 2024

    Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. rnavon@post.tau.ac.il.

    Papers in Europe PMC
  8. 08
    Platt FM4 papers · 2018

    Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK. fran@glycob.ox.ac.uk

    Papers in Europe PMC
  9. 09
    Stephen CD4 papers · 2025

    NTSAD Association, Brookline, MA, USA.

    Papers in Europe PMC
  10. 10
    Toro C4 papers · 2026

    National Institutes of Health, Bethesda, MD, USA.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name. 3 observational studies did — shown below because natural-history and cohort work can be an important step toward a trial. 11 trials are registered for Tay-Sachs disease, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

11 interventional trials matched Tay-Sachs disease, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: Tay-Sachs disease

11

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Tay-Sachs disease, adult form" OR "Beta-hexosaminidase subunit alpha deficiency, adult  form" OR "GM2 gangliosidosis, Tay-Sachs variant, adult form" OR "GM2 gangliosidosis, hexosaminidase A deficiency variant, adult form" OR "HEXA disorder, adult form" OR "Late-onset Tay-Sachs disease" OR "GM2 gangliosidosis, B variant, adult form" OR "hexosaminidase A deficiency, adult form"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Tay-Sachs disease, adult form" OR "Beta-hexosaminidase subunit alpha deficiency, adult  form" OR "GM2 gangliosidosis, Tay-Sachs variant, adult form" OR "GM2 gangliosidosis, hexosaminidase A deficiency variant, adult form" OR "HEXA disorder, adult form" OR "Late-onset Tay-Sachs disease" OR "GM2 gangliosidosis, B variant, adult form" OR "hexosaminidase A deficiency, adult form"

Study-type breakdown: 0 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"Tay-Sachs disease"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T12:55:41.381Z